Nutritional status and growth in pediatric crohn's disease: A population-based study

American Journal of Gastroenterology

Volumn 105, Issue 8, 2010, Pages 1893-1900

  Vasseur, Francis ^a   Gower Rousseau, Corinne ^a   Vernier Massouille, Gwenola ^a   Dupas, Jean Louis ^b   Merle, Veronique ^c   Merlin, Beatrice ^a   Lerebours, Eric ^c   Savoye, Guillaume ^c   Salomez, Jean Louis ^a   Cortot, Antoine ^a   Colombel, Jean Frederic ^a   Turck, Dominique ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FOLLOW UP; GROWTH RETARDATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL STATUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

EID: 77955423917     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.20     Document Type: Article

References (37)

1. Auvin S, Molinie F, Gower-Rousseau C et al. Incidence, clinical presentationand location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999).J Pediatr Gastroenterol Nutr 2005; 41: 49-55.
2. Langholz E, Munkholm P, Krasilnikoff PA et al. Inflammatory bowel diseaseswith onset in childhood. Clinical features, morbidity, and mortality ina regional cohort. Scand J Gastroenterol 1997; 32: 139-147
3. Winter TA, O'Keefe SJ, Callanan M et al. Impaired gastric acid and pancreaticenzyme secretion in patients with Crohn's disease may be a consequenceof a poor nutritional state. Inflamm Bowel Dis 2004; 10: 618-625
4. Rigaud D, Cerf M, Angel Alberto L et al. Increase of resting energyexpenditure during flare-ups in Crohn disease. Gastroenterol Clin Biol1993; 17: 932-937
5. Kundhal P, Zachos M, Holmes JL et al. Controlled ileal release budesonidein pediatric Crohn disease: effi cacy and eff ect on growth. J Pediatr GastroenterolNutr 2001; 33: 75-80.
6. Ballinger A. Management of growth retardation in the young patient withCrohn's disease. Expert Opin Pharmacother 2002; 3: 1-7.
7. Leonard MB. Glucocorticoid-induced osteoporosis in children: impact ofthe underlying disease. Pediatrics 2007; 119 (Suppl 2): S166-74.
8. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in childrenand adolescents before the diagnosis of Crohn's disease. Gastroenterology1988; 95: 1523-1527
9. Farmer RG, Michener WM. Prognosis of Crohn's disease with onset inchildhood or adolescence. Dig Dis Sci 1979; 24: 752-757
10. Sentongo TA, Semeao EJ, Piccoli DA et al. Growth, body composition, andnutritional status in children and adolescents with Crohn's disease. J PediatrGastroenterol Nutr 2000; 31: 33-40.
11. Alemzadeh N, Rekers-Mombarg LT, Mearin ML et al. Adult height inpatients with early onset of Crohn's disease. Gut 2002; 51: 26-29
12. Markowitz J, Grancher K, Rosa J et al. Growth failure in pediatric inflammatorybowel disease. J Pediatr Gastroenterol Nutr 1993; 16: 373-380
13. Gower-Rousseau C, Salomez JL, Dupas JL et al. Incidence of inflammatorybowel disease in northern France (1988-1990). Gut 1994; 35: 1433-1438
14. Molini é F, Gower-Rousseau C, Yzet T et al. Opposite evolution in incidenceof Crohn's disease and ulcerative colitis in northern France (1988-1999).Gut 2004; 53: 843-848
15. Satsangi J, Silverberg MS, Vermeire S et al. The Montreal classification ofinflammatory bowel disease: controversies, consensus, and implications.Gut 2006; 55: 749-753
16. Henriksen M, Jahnsen J, Lygren I et al. C-reactive protein: a predictivefactor and marker of inflammation in inflammatory bowel disease. Resultsfrom a prospective population-based study. Gut 2008; 57: 1518-1523
17. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS methodand penalized likelihood. Stat Med 1992; 11: 1305-1319
18. Freeman JV, Cole TJ, Chinn S et al. Cross sectional stature and weight referencecurves for the UK, 1990. Arch Dis Child 1995; 73: 17-24.
19. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for theUK, 1990. Arch Dis Child 1995; 73: 25-29
20. Baron S, Turck D, Leplat C et al. Environmental risk factors in paediatricinflammatory bowel diseases: a population based case control study. Gut2005; 54: 357-363
21. Conover WJ, Iman RL. Rank transformation as a bridge between parametricand nonparametric statistics. Am Stat 1981; 35: 124-133
22. D'Agostino RB Jr. Propensity score methods for bias reduction in thecomparison of a treatment to a non-randomized control group. Stat Med1998; 17: 2265-2281
23. Patel HI, Leichtner AM, Colodny AH et al. Surgery for Crohn's disease ininfants and children. J Pediatr Surg 1997; 32: 1063-7. discussion 1067-1068
24. Vernier-Massouille G, Balde M, Salleron J et al. Natural history of pediatricCrohn's disease: a population-based cohort study. Gastroenterology2008; 135: 1106-1113
25. Munkholm P, Langholz E, Davidsen M et al. Intestinal cancer risk and mortalityin patients with Crohn's disease. Gastroenterology 1993; 105: 1716-1723
26. Motil KJ, Grand RJ, Davis-Kraft L et al. Growth failure in children with inflammatorybowel disease: a prospective study. Gastroenterology 1993; 105: 681-691
27. Sawczenko A, Ballinger AB, Savage MO et al. Clinical features aff ectingfinal adult height in patients with pediatric-onset Crohn's disease. Pediatrics2006; 118: 124-129
28. Pfefferkorn M, Burke G, Griffiths A et al. Growth abnormalities persist innewly diagnosed children with Crohn disease despite current treatmentparadigms. J Pediatr Gastroenterol Nutr 2009; 48: 168-174
29. Sawczenko A, Lynn R, Sandhu BK. Variations in initial assessment andmanagement of inflammatory bowel disease across Great Britain andIreland. Arch Dis Child 2003; 88: 990-994
30. Sawczenko A, Azooz O, Paraszczuk J et al. Intestinal inflammation- inducedgrowth retardation acts through IL-6 in rats and depends on the-174 IL-6G/C polymorphism in children. Proc Natl Acad Sci USA 2005; 102: 13260-13265
31. Shamir R, Phillip M, Levine A. Growth retardation in pediatric Crohn'sdisease: pathogenesis and interventions. Inflamm Bowel Dis 2007; 13: 620-628
32. Griffiths AM, Nguyen P, Smith C et al. Growth and clinical course of childrenwith Crohn's disease. Gut 1993; 34: 939-943
33. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturityfor height, weight, height velocity, and weight velocity: British children,1965. Arch Dis Child 1966; 41: 454-471
34. Lifshitz F. Pediatric Endocrinology: A Clinical Guide. Marcel Dekker: NewYork, 1990.
35. Gryboski JD. Crohn's disease in children 10 years old and younger: comparisonwith ulcerative colitis. J Pediatr Gastroenterol Nutr 1994; 18: 174-182
36. Ardizzone S, Bianchi Porro G. The topical treatment of distal ulcerativecolitis. Eur J Gastroenterol Hepatol 1996; 8: 599-602.
37. Walters T, Gilman AR, Griffiths AM. Linear growth improves during infliximabtherapy in children with chronically active severe Crohn's disease.Inflamm Bowel Dis 2007; 13: 424-430